Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122759143 | 12275914 | 3 | F | 20141223 | 20160719 | 20160418 | 20160801 | EXP | GB-MHRA-ADR 22852840 | GB-ACCORD-030344 | ACCORD | 46.00 | YR | M | Y | 0.00000 | 20160730 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122759143 | 12275914 | 1 | PS | CISPLATIN. | CISPLATIN | 1 | 206774 | ||||||||||||
| 122759143 | 12275914 | 2 | SS | ZAPONEX | CLOZAPINE | 1 | Oral | RECEIVED AT NIGHT. LAST ADMINISTRATION DATE 20-MAR-2016.SWITCHED TO SUSPENSION MAY/JUN 2015 | 1332000 | MG | Y | 0 | 600 | MG | QD | ||||
| 122759143 | 12275914 | 3 | C | GRANULOKINE | FILGRASTIM | 1 | FILGRASTIM | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122759143 | 12275914 | 1 | Laryngeal cancer |
| 122759143 | 12275914 | 2 | Product used for unknown indication |
| 122759143 | 12275914 | 3 | Neutropenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122759143 | 12275914 | DE |
| 122759143 | 12275914 | DS |
| 122759143 | 12275914 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122759143 | 12275914 | Drug effect incomplete | |
| 122759143 | 12275914 | Haemoglobin decreased | |
| 122759143 | 12275914 | Laryngeal cancer stage IV | |
| 122759143 | 12275914 | Leukopenia | |
| 122759143 | 12275914 | Lymphopenia | |
| 122759143 | 12275914 | Metastases to lymph nodes | |
| 122759143 | 12275914 | Neutropenia | |
| 122759143 | 12275914 | Neutrophil count decreased | |
| 122759143 | 12275914 | Neutrophil count increased | |
| 122759143 | 12275914 | Off label use | |
| 122759143 | 12275914 | Platelet count decreased | |
| 122759143 | 12275914 | Platelet count increased | |
| 122759143 | 12275914 | Product use issue | |
| 122759143 | 12275914 | White blood cell count decreased | |
| 122759143 | 12275914 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122759143 | 12275914 | 1 | 201503 | 0 | ||
| 122759143 | 12275914 | 2 | 20081124 | 20150417 | 0 | |
| 122759143 | 12275914 | 3 | 201504 | 0 |